Eustachian Tube Dysfunction Treatment Market - Top Companies and Manufacturers

  • Report ID: 5847
  • Published Date: Mar 08, 2024
  • Report Format: PDF, PPT

Companies Dominating the Eustachian Tube Dysfunction Treatment Landscape

top-features-companies
    • Candela Healthcare Pvt. Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Torque Pharmaceuticals.
    • Cipla Ltd.
    • Dr. Reddy's Laboratories.
    • FDC Limited.
    • Glenmark Pharmaceuticals Limited.
    • Leeford Healthcare Ltd.
    • Novartis AG.
    • Pfizer Inc.
    • Sanofi SA

Browse Key Market Insights with Data Illustration:

In the News

  • Cipla agreed to further invest INR 42 crores in digital tech company GoApptiv. With the completion of this deal, Cipla’s total stake in GoApptiv will increase to 22.99% on a fully diluted basis. This is Cipla’s third investment in GoApptiv, which will be made in a combination of equity shares and compulsorily convertible preference shares.
  • Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization for VELSIPITY in the European Union to treat patients 16 years of age and older with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy, or a biological agent.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5847
  • Published Date: Mar 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The rising prevalence of infections like sinuses, cold, flu and allergies, surge in the smoking population, growing instance of ear infections, and prevalence of obesity are the major factors driving the growth of the eustachian tube dysfunction treatment market.

The market size of Eustachian tube dysfunction treatment is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2024 – 2036.

The major players in the market are Candela Healthcare Private Limited, Cipla Ltd, Dr. Reddy's Laboratories, FDC Limited.Glenmark Pharmaceuticals Limited, Leeford Healthcare Ltd, Novartis AG, Pfizer Inc. and others.

The hospital segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying